These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

466 related items for PubMed ID: 20043850

  • 21. Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma.
    Gee GV, Koestler DC, Christensen BC, Sugarbaker DJ, Ugolini D, Ivaldi GP, Resnick MB, Houseman EA, Kelsey KT, Marsit CJ.
    Int J Cancer; 2010 Dec 15; 127(12):2859-69. PubMed ID: 21351265
    [Abstract] [Full Text] [Related]

  • 22. Read-Split-Run: an improved bioinformatics pipeline for identification of genome-wide non-canonical spliced regions using RNA-Seq data.
    Bai Y, Kinne J, Donham B, Jiang F, Ding L, Hassler JR, Kaufman RJ.
    BMC Genomics; 2016 Aug 22; 17 Suppl 7(Suppl 7):503. PubMed ID: 27556805
    [Abstract] [Full Text] [Related]

  • 23. Deep RNA sequencing analysis of readthrough gene fusions in human prostate adenocarcinoma and reference samples.
    Nacu S, Yuan W, Kan Z, Bhatt D, Rivers CS, Stinson J, Peters BA, Modrusan Z, Jung K, Seshagiri S, Wu TD.
    BMC Med Genomics; 2011 Jan 24; 4():11. PubMed ID: 21261984
    [Abstract] [Full Text] [Related]

  • 24. Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers.
    Bononi I, Comar M, Puozzo A, Stendardo M, Boschetto P, Orecchia S, Libener R, Guaschino R, Pietrobon S, Ferracin M, Negrini M, Martini F, Bovenzi M, Tognon M.
    Oncotarget; 2016 Dec 13; 7(50):82700-82711. PubMed ID: 27716620
    [Abstract] [Full Text] [Related]

  • 25. A molecular diagnostic test for distinguishing lung adenocarcinoma from malignant mesothelioma using cells collected from pleural effusions.
    Holloway AJ, Diyagama DS, Opeskin K, Creaney J, Robinson BW, Lake RA, Bowtell DD.
    Clin Cancer Res; 2006 Sep 01; 12(17):5129-35. PubMed ID: 16951230
    [Abstract] [Full Text] [Related]

  • 26. Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma.
    Goto Y, Shinjo K, Kondo Y, Shen L, Toyota M, Suzuki H, Gao W, An B, Fujii M, Murakami H, Osada H, Taniguchi T, Usami N, Kondo M, Hasegawa Y, Shimokata K, Matsuo K, Hida T, Fujimoto N, Kishimoto T, Issa JP, Sekido Y.
    Cancer Res; 2009 Dec 01; 69(23):9073-82. PubMed ID: 19887624
    [Abstract] [Full Text] [Related]

  • 27. Diagnostic potential of miR-126, miR-143, miR-145, and miR-652 in malignant pleural mesothelioma.
    Andersen M, Grauslund M, Ravn J, Sørensen JB, Andersen CB, Santoni-Rugiu E.
    J Mol Diagn; 2014 Jul 01; 16(4):418-30. PubMed ID: 24912849
    [Abstract] [Full Text] [Related]

  • 28. Methylation-associated Silencing of microRNA-126 and its Host Gene EGFL7 in Malignant Pleural Mesothelioma.
    Andersen M, Trapani D, Ravn J, Sørensen JB, Andersen CB, Grauslund M, Santoni-Rugiu E.
    Anticancer Res; 2015 Nov 01; 35(11):6223-9. PubMed ID: 26504055
    [Abstract] [Full Text] [Related]

  • 29. Gene expression profiling identifies matriptase overexpression in malignant mesothelioma.
    Hoang CD, D'Cunha J, Kratzke MG, Casmey CE, Frizelle SP, Maddaus MA, Kratzke RA.
    Chest; 2004 May 01; 125(5):1843-52. PubMed ID: 15136399
    [Abstract] [Full Text] [Related]

  • 30. Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens.
    Liao W, Jordaan G, Nham P, Phan RT, Pelegrini M, Sharma S.
    BMC Cancer; 2015 Oct 16; 15():714. PubMed ID: 26474785
    [Abstract] [Full Text] [Related]

  • 31. Validation of genomics-based prognostic tests in malignant pleural mesothelioma.
    Gordon GJ, Rockwell GN, Godfrey PA, Jensen RV, Glickman JN, Yeap BY, Richards WG, Sugarbaker DJ, Bueno R.
    Clin Cancer Res; 2005 Jun 15; 11(12):4406-14. PubMed ID: 15958625
    [Abstract] [Full Text] [Related]

  • 32. The Usage of Exon-Exon Splice Junctions for the Detection of Alternative Splicing using the REIDS model.
    Van Moerbeke M, Kasim A, Shkedy Z.
    Sci Rep; 2018 May 29; 8(1):8331. PubMed ID: 29844567
    [Abstract] [Full Text] [Related]

  • 33. Tumor-specific genetic variants can be detected in circulating cell-free DNA of malignant pleural mesothelioma patients.
    Hylebos M, Op de Beeck K, Pauwels P, Zwaenepoel K, van Meerbeeck JP, Van Camp G.
    Lung Cancer; 2018 Oct 29; 124():19-22. PubMed ID: 30268460
    [Abstract] [Full Text] [Related]

  • 34. BAP1 missense mutation c.2054 A>T (p.E685V) completely disrupts normal splicing through creation of a novel 5' splice site in a human mesothelioma cell line.
    Morrison A, Chekaluk Y, Bacares R, Ladanyi M, Zhang L.
    PLoS One; 2015 Oct 29; 10(4):e0119224. PubMed ID: 25830670
    [Abstract] [Full Text] [Related]

  • 35. Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays.
    Johnson JM, Castle J, Garrett-Engele P, Kan Z, Loerch PM, Armour CD, Santos R, Schadt EE, Stoughton R, Shoemaker DD.
    Science; 2003 Dec 19; 302(5653):2141-4. PubMed ID: 14684825
    [Abstract] [Full Text] [Related]

  • 36. Molecular classification of malignant pleural mesothelioma: identification of a poor prognosis subgroup linked to the epithelial-to-mesenchymal transition.
    de Reyniès A, Jaurand MC, Renier A, Couchy G, Hysi I, Elarouci N, Galateau-Sallé F, Copin MC, Hofman P, Cazes A, Andujar P, Imbeaud S, Petel F, Pairon JC, Le Pimpec-Barthes F, Zucman-Rossi J, Jean D.
    Clin Cancer Res; 2014 Mar 01; 20(5):1323-34. PubMed ID: 24443521
    [Abstract] [Full Text] [Related]

  • 37. Mechanisms of FUS1/TUSC2 deficiency in mesothelioma and its tumorigenic transcriptional effects.
    Ivanova AV, Ivanov SV, Prudkin L, Nonaka D, Liu Z, Tsao A, Wistuba I, Roth J, Pass HI.
    Mol Cancer; 2009 Oct 24; 8():91. PubMed ID: 19852844
    [Abstract] [Full Text] [Related]

  • 38. Alternative Splicing Signatures in RNA-seq Data: Percent Spliced in (PSI).
    Schafer S, Miao K, Benson CC, Heinig M, Cook SA, Hubner N.
    Curr Protoc Hum Genet; 2015 Oct 06; 87():11.16.1-11.16.14. PubMed ID: 26439713
    [Abstract] [Full Text] [Related]

  • 39. Exon array analysis of head and neck cancers identifies a hypoxia related splice variant of LAMA3 associated with a poor prognosis.
    Moller-Levet CS, Betts GN, Harris AL, Homer JJ, West CM, Miller CJ.
    PLoS Comput Biol; 2009 Nov 06; 5(11):e1000571. PubMed ID: 19936049
    [Abstract] [Full Text] [Related]

  • 40. Identification of genes and pathways involved in malignant pleural mesothelioma using bioinformatics methods.
    Liu X, Qian K, Lu G, Chen P, Zhang Y.
    BMC Med Genomics; 2021 Apr 13; 14(1):104. PubMed ID: 33849532
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.